+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Epilepsy Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Generation Category (First-Generation Anti-Epileptic Drugs , Second-Generation Anti-Epileptic Drugs , Third-Generation Anti-Epileptic Drugs ), By Seizure (Focal , Generalized Seizure Treatment, Refractory , Rare Epilepsy Syndromes ), By Route of Administration (Oral , Intravenous , Nasal ), By Patient Demographics (Adult Patients, Pediatric & Infant Patients, Geriatric Patients), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Outpatient Drug Stores, Online) Companies, and Country Forecast, 2021 to 2034

Global Epilepsy Drugs Market size is forecast to increase from $13.23 Billion in 2026 to $20.93 Billion in 2034 at a CAGR of 5.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007107
Pages: 226 Pages

Epigenetics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents & Consumables , Assay Kits, Laboratory Instruments & Sequencers, Software & Data Analytics Tools), By Technology (DNA Methylation, Histone Acetylation & Methylation, Chromatin Remodeling & Mapping, RNA Modification ), By Application (Oncology , Non-Oncology , Developmental Biology & Immunology), By End-User (Pharmaceutical & Biotechnology Companies, Academic, Government, & Independent Research Institutes, Contract Research Organizations , Clinical & Diagnostic Testing Facilities) Companies, and Country Forecast, 2021 to 2034

Global Epigenetics Market size is forecast to increase from $20.83 Billion in 2026 to $65.06 Billion in 2034 at a CAGR of 15.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007106
Pages: 210 Pages

Epigenetics Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product (Kits & Reagents , Instruments & High-Throughput Hardware, Bioinformatics Software & Analytical Services), By Technology (DNA Methylation Analysis, Histone Methylation & Modification Analysis, MicroRNA & Non-Coding RNA Modification, Chromatin Structures & Immunoprecipitation ), By Application (Oncology Diagnostics , Non-Oncology Diagnostics ), By End-User (Clinical Diagnostic Laboratories, Hospitals & Medical Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Epigenetics Diagnostics Market size is forecast to increase from $22 Billion in 2026 to $66.37 Billion in 2034 at a CAGR of 14.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007105
Pages: 227 Pages

Epidermolysis Bullosa Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Epidermolysis Bullosa Simplex , Dystrophic Epidermolysis Bullosa , Junctional Epidermolysis Bullosa , Kindler Syndrome), By Drug Class (Antibiotics, Analgesics , Corticosteroids, Gene & Cell Therapies), By Mode of Administration (Topical , Injectables, Oral), By End-User (Hospitals and Clinics, Specialty Dermatology Centers, Homecare Settings, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Epidermolysis Bullosa Therapeutics Market size is forecast to increase from $3.37 Billion in 2026 to $5.13 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007104
Pages: 224 Pages

EPharmacy Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Prescription Drugs, Over-the-Counter ), By Product Type (Skin Care, Dental Products, Cold & Flu Medications, Vitamins & Dietary Supplements, Weight Management Products), By Therapeutic Area (Diabetes, Cardiovascular, Respiratory, Gastrointestinal, Pain Management), By Platform (Mobile Applications, Desktop) Companies, and Country Forecast, 2021 to 2034

Global ePharmacy Market size is forecast to increase from $111.41 Billion in 2026 to $522.17 Billion in 2034 at a CAGR of 21.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007103
Pages: 218 Pages

Enzyme Replacement Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Enzyme Type (Imiglucerase, Agalsidase Alfa, Agalsidase Beta, Velaglucerase Alfa, Taliglucerase Alfa, Alglucosidase Alfa, Avalglucosidase Alfa, Others), By Application (Gaucher Disease, Pompe Disease, Fabry Disease, Mucopolysaccharidosis , Lysosomal Acid Lipase Deficiency, Others), By Route of Administration (Intravenous Infusion, Subcutaneous, Oral), By Formulation (Standard Recombinant Enzyme, PEGylated, Gene-Activated Next-Generation Enzymes), By End User (Hospitals & Specialty Clinics, Home Healthcare Settings, Infusion Centers) Companies, and Country Forecast, 2021 to 2034

Global Enzyme Replacement Therapy Market size is forecast to increase from $13.22 Billion in 2026 to $27.13 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007102
Pages: 210 Pages

Enzyme Inhibitors Market Size, Share and Growth Outlook, 2026: Analysis By Type (Reversible Inhibitors, Irreversible Inhibitors), By Therapeutic Class (Proton Pump Inhibitors , Protease Inhibitors, Reverse Transcriptase Inhibitors, Kinase Inhibitors, Others), By Application (Pharmaceutical, Agrochemical, Food & Beverage, Diagnostics & Research), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations , Industrial Manufacturing) Companies, and Country Forecast, 2021 to 2034

Global Enzyme Inhibitors Market size is forecast to increase from $2.8 Billion in 2026 to $5.07 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007101
Pages: 219 Pages

Enzyme Immunoassay Market Size, Share and Growth Outlook, 2026: Analysis By Product (Reagents & Kits, Analyzers, Software & Services, Consumables & Accessories), By Technology (Enzyme-Linked Immunosorbent Assay , Chemiluminescence Enzyme Immunoassay , Enzyme-Linked Immunospot , Others), By Application (Infectious Disease Testing, Oncology, Cardiology, Autoimmune Diseases, Endocrinology, Therapeutic Drug Monitoring, Allergy Testing), By Specimen Type (Blood, Saliva, Urine, Other Specimens), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Enzyme Immunoassay Market size is forecast to increase from $20.13 Billion in 2026 to $29.52 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007100
Pages: 228 Pages

Enzymatic Wound Debridement Market Size, Share and Growth Outlook, 2026: Analysis By Type (Chronic Wounds, Acute Wounds), By Product (Collagenase Products, Papain Products, Others), By End-User (Hospitals, Homecare Settings, Others) Companies, and Country Forecast, 2021 to 2034

Global Enzymatic Wound Debridement Market size is forecast to increase from $1.17 Billion in 2026 to $1.97 Billion in 2034 at a CAGR of 6.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007099
Pages: 215 Pages

Enzymatic DNA Synthesis Market Size, Share and Growth Outlook, 2026: Analysis By Offering (Products , Services), By Synthesis Approach (Template-free Enzymatic Assembly, Template-based Enzymatic Assembly), By Application (Synthetic Biology, Vaccine Development, Gene Therapy, Therapeutic Innovation), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations , Contract Development and Manufacturing Organizations) Companies, and Country Forecast, 2021 to 2034

Global Enzymatic DNA Synthesis Market size is forecast to increase from $516.14 Million in 2026 to $3258.17 Million in 2034 at a CAGR of 25.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007098
Pages: 228 Pages